GZMB Antibody (N-term) Blocking Peptide

GZMB Antibody (N-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP6575a
Catalog Number: AC-BP6575a
Size: 500 µg
Datasheet
Request Information
Background:
Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.

Other Names:
Granzyme B, C11, CTLA-1, Cathepsin G-like 1, CTSGL1, Cytotoxic T-lymphocyte proteinase 2, Lymphocyte protease, Fragmentin-2, Granzyme-2, Human lymphocyte protein, HLP, SECT, T-cell serine protease 1-3E, GZMB, CGL1, CSPB, CTLA1, GRB

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6575a was selected from the N-term region of human GZMB. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: GZMB {ECO:0000303|PubMed:32188940, ECO:0000312|HGNC:HGNC:4709}

Gene ID: 3002
Primary Accession: P10144
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:GZMB Antibody (N-term) Blocking Peptide